Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3196196

Beta release

Statistics of Efficacy and safety of guselkumab, an interleukin-23p 19-specific monoclonal antibody, through one year in biologic-naive patients with psoriatic arthritis
Statistics for this year
PeriodVisitsDownloads
20245551
Statistics for the last 3 months
PeriodVisitsDownloads
2024-09106
2024-1044
2024-1144